| Zipporah Matsunaga, PHARMD | |
|
12254 Bellflower Blvd Ste 106, Downey, CA 90242-2804 | |
| (562) 658-3578 | |
| Not Available |
| Full Name | Zipporah Matsunaga |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 12254 Bellflower Blvd Ste 106, Downey, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336772045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 41436 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Zipporah Matsunaga, PHARMD 12254 Bellflower Blvd Ste 106, Downey, CA 90242-2804 Ph: () - | Zipporah Matsunaga, PHARMD 12254 Bellflower Blvd Ste 106, Downey, CA 90242-2804 Ph: (562) 658-3578 |
News Archive
Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases.
Merck & Co., Inc., and SmartCells, Inc., today announced that they have entered into a definitive agreement under which Merck will acquire SmartCells, a private company developing a glucose responsive insulin formulation for the treatment of diabetes mellitus.
A bit of pressure from a new shrinking, sponge-like gel is all it takes to turn transplanted unspecialized cells into cells that lay down minerals and begin to form teeth.
A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer's disease than a single memory test. This is one more piece of information to aid in the identification and early treatment of individuals most likely to develop Alzheimer's disease.
Avaxia Biologics, Inc., a privately-held biotechnology company developing oral antibody drugs that act locally within the digestive tract, announced today that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AVX-470 for the treatment of ulcerative colitis.
› Verified 5 days ago
Lindy Garrison, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9161 Via Amorita, Downey, CA 90241 Phone: 562-879-3616 | |
Erwin W.s. Jeong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12254 Bellflower Blvd, Drug Info - 1st Floor, Downey, CA 90242 Phone: 562-658-3751 | |
Nikki Du, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9449 Imperial Hwy, Downey, CA 90242 Phone: 562-657-2334 | |
Michael Luhm, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9333 Imperial Hwy, 1st Floor Outpatient Pharmacy, Downey, CA 90242 Phone: 562-657-9421 | |
Dr. Joon Cha, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9449 Imperial Hwy, Downey, CA 90242 Phone: 562-657-2026 | |
Danny D Lam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9521 Dalen St, Downey, CA 90242 Phone: 866-206-2983 | |
Dr. Abraham Koun-kuk Kim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12254 Bellflower Blvd Fl 2, Downey, CA 90242 Phone: 562-774-5029 |